XDR-TB--danger ahead.
Singh
M M
MM
D000995:Antitubercular Agents / Q000627:therapeutic use*; D014943:Global Health; D006801:Humans; D015994:Incidence; D007538:Isoniazid / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use; D012307:Risk Factors; D018088:Tuberculosis, Multidrug-Resistant / Q000453:epidemiology*
D000995:Antitubercular Agents; D007538:Isoniazid; D012293:Rifampin